Psychiatry Patient Characteristics Affect Communication with Provider

Article

Outcomes of a computer-mediated intervention called DIALOG depend on characteristics of the particular patient.

According to study results to be published by Swedish researchers in the November issue of Acta Psychiatrica Scandinavica, outcomes of a computer-mediated intervention called DIALOG—that “structures communication between [psychiatry] patients and key workers during routine meetings to consistently address life domains and treatment concerns via assessment of patient satisfaction”—depend on characteristics of the particular patient. The current study adds to previous research that found the intervention to positively affect communication at one year, by determining if the ability of DIALOG to produce positive results was affected by patient baseline sociodemographic, clinical, and social characteristics.

After looking at one-year follow-up in 507 schizophrenia patients who were randomly assigned to either DIALOG intervention or standard therapy, the researchers found greater quality of life improvements in patients who had more severe negative symptoms at baseline, with those receiving intervention experiencing the greatest improvements if they “had a better initial relationship with their key worker and a shorter duration of illness.” Further, DIALOG intervention resulted in significantly greater reductions in unmet needs among those who were in competitive employment and had shorter illness duration. Better treatment satisfaction improvements were seen at follow-up with those in the intervention group if they were elderly.

Related Videos
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
Understanding the Link Between Substance Use and Psychiatric Symptoms, with Randi Schuster, PhD
Andrew Miller, PhD: Inventor of KarXT Discusses Pivotal EMERGENT-2 Data
© 2024 MJH Life Sciences

All rights reserved.